London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Efficiency of ExPRESS (Alcon) device implantation in the complex treatment of open-angle glaucoma combined with cataract, depending on the severity of glaucoma

Poster Details

First Author: G.Parkhomenko UKRAINE

Co Author(s):    S. Medvedchuk   M. Beliy   Y. Gnatenko   T. Petrovskaya     

Abstract Details


The aim of this study is to estimate the efficacy of the EX-PRESS microdraining device implantation in complex treatment of open-angle glaucoma combined with cataract depending on the stage of the glaucoma process.


The system of medical centers «Noviy Zir» Kyiv, Cherkassy. Ukraine


73 patients (73 eyes) were divided into two groups depending on the method of the glaucoma surgery. The 1st group included 41 patients (41eyes) who underwent the EX-PRESS microdraining device (diameter 50 µm) implantation combined with phacoemulsification. In the 2nd group, which included 32 patients (32 eyes), non-penetrating sclerectomy combined with phacoemulsification was performed . We performed visometry, tonometry, gonioscopy, ophthalmoscopy, pachymetry and optical coherence tomography (the ganglion cells complex and the nerve fiber layer thickness) before the operation and 24 months after the surgery.


According to the data, the glaucoma process stabilization was achieved in 97% of cases of mild (stage 1) and moderate (stage2) glaucoma in the group where EX-PRESS mini shunt implantation combined with the phacoemulsification was performed. Stabilization of the glaucoma process was achieved in 92 % of cases in stage 1-2 glaucoma in the group where non-penetrating sclerectomy was performed. In the patients with advanced (stage 3) glaucoma stabilization was achieved in 93% of cases in group 1, and in 89% in the 2nd group.


Long-term gradual IOP reduction and safety of Ex-PRESS glaucoma device implantation may be the reason of choice of this surgery method both for patients with mild- and moderate-stage glaucoma and with advanced-stage glaucoma. FINANCIAL INTEREST: NONE

Back to Poster listing